Unveiling four axes ADAMTS9-AS2|MEG3/hsa-miR-150/PRKCA|MMP14 within prostate cancer through establishment of the ceRNA network
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Mohammad Taheri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, Jena University Hospital, Jena, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, MicroRNAs, Gene Regulatory Networks, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Krebshilfe.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Genetics, Jena University Hospital, Jena, Germany.
- Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Institute of Human Genetics, Jena University Hospital, Jena, Germany. Electronic address: aria.baniahmad@med.uni-jena.de.
Förderung
- Deutsche Krebshilfe
Zitieren
APA
Taheri, M., Safarzadeh, A., & Baniahmad, A. (2024). Unveiling four axes ADAMTS9-AS2|MEG3/hsa-miR-150/PRKCA|MMP14 within prostate cancer through establishment of the ceRNA network. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155604
Vancouver
Taheri M, Safarzadeh A, Baniahmad A. Unveiling four axes ADAMTS9-AS2|MEG3/hsa-miR-150/PRKCA|MMP14 within prostate cancer through establishment of the ceRNA network. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155604
BibTeX
@article{Taheri2024,
author = {Taheri, Mohammad and Safarzadeh, Arash and Baniahmad, Aria},
title = {Unveiling four axes ADAMTS9-AS2|MEG3/hsa-miR-150/PRKCA|MMP14 within prostate cancer through establishment of the ceRNA network},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155604}
}
EUVIMED